C4 Therapeutics Newsroom

Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), ACADIA Pharmaceuticals (ACAD) and Disc Medicine (IRON)

TipRanksMay 12 22:15 ET

C4 Therapeutics Analyst Ratings

BenzingaMay 9 09:58 ET

C4 Therapeutics: Hold Rating Maintained Amidst Encouraging Drug Progress and Stable Financials

TipRanksMay 9 06:35 ET

C4 Therapeutics Analyst Ratings

BenzingaFeb 26 10:40 ET

Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), Halozyme (HALO) and Eli Lilly & Co (LLY)

TipRanksFeb 26 07:30 ET

C4 Therapeutics Analyst Ratings

BenzingaFeb 23 08:46 ET

Strong Financials and Promising Drug Pipeline Bolster Buy Rating for C4 Therapeutics

TipRanksFeb 23 07:40 ET

Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), Insulet (PODD) and Healthequity (HQY)

TipRanksFeb 23 07:40 ET

Stifel Nicolaus Sticks to Its Buy Rating for C4 Therapeutics (CCCC)

TipRanksFeb 23 07:22 ET

Analysts Conflicted on These Healthcare Names: C4 Therapeutics (CCCC), Eli Lilly & Co (LLY) and Irhythm Technologies (IRTC)

TipRanksFeb 23 06:01 ET

JP Morgan Upgrades C4 Therapeutics to Neutral, Cites Pipeline

Seeking AlphaJan 29 13:58 ET

C4 Therapeutics Analyst Ratings

BenzingaJan 29 05:43 ET

C4 Therapeutics: Strategic Partnerships and Clinical Advancements Bolster Buy Rating

TipRanksJan 12 08:26 ET

C4 Therapeutics: Hold Rating Maintained Amidst Early Data and Collaboration Potential

TipRanksDec 13, 2023 04:47 ET

Stifel Upgrades C4 Therapeutics to Buy, Raises Price Target to $12

BenzingaDec 13, 2023 04:16 ET

C4 Therapeutics Analyst Ratings

BenzingaDec 13, 2023 04:14 ET

Morgan Stanley Upgrades C4 Therapeutics to Equal-Weight, Lowers Price Target to $1

BenzingaNov 6, 2023 07:51 ET

C4 Therapeutics Analyst Ratings

BenzingaNov 6, 2023 07:50 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Seagen (SGEN), IQVIA Holdings (IQV) and C4 Therapeutics (CCCC)

TipRanksNov 6, 2023 01:40 ET

C4 Therapeutics Analyst Ratings

BenzingaNov 3, 2023 11:30 ET